British pharma firm claims small trial on a coronavirus treatment could signal 'major breakthrough'

  • 📰 CNBC
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 72%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.

The company said its nebulizer treatment produced a 79% lower risk of patients developing severe disease than those given a placebo in initial trials.

The company said its nebulizer treatment produced a 79% lower risk of patients developing severe disease than those given a placebo in initial trials, and patients that received the treatment "were more than twice as likely to recover over the course of the treatment period compared to those receiving placebo," Synairgen claimed.

The drug, SNG001, is a formulation of a naturally-occurring antiviral protein called interferon beta inhaled directly into the lungs, in the hope of stimulating an immune response. The treatment is aimed at preventing infected patients deteriorating from requiring oxygen to being placed on a ventilator.

"Our efforts are now focused on working with the regulators and other key groups to progress this potential Covid-19 treatment as rapidly as possible."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Could signal. lol.

Won't matter much in the end, investors!

I thought we save vaccine news for red days?

could, would, should just adds to fake news and do nothing to help. Report the did, done, approved, safe.

TheDiamondBoy10

The smaller the trial, the bigger the breakthru ... hmmm ... OK ...

Just before market open! What a surprise

Amazing!! Stock up 3.5x already on market opening 🙊

Every disease ever was cured before a phase 3 trial was sucessful

Who needs stimulus when you have vaccine pumps?

WeDontCare

Need P3 placebo-controlled studies (determine if double-blinding maintained), if not remdesivir control - UK pharma claims small clin study of respiratory nebulizer treatment for coronavirus vs placebo lowered risk 79% of developing severe disease (N=101) s

Read this

Market manipulation at its finest, new week same old bullshit headlines.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Netanyahu's graft trial resumes amid Israeli virus angerJERUSALEM (AP) — Israeli Prime Minister Benjamin Netanyahu’s corruption trial resumed on Sunday, as the long-serving leader faces mounting discontent over his handling of the coronavirus... Maybe 2020 won't be so bad after all! Getting rid of Trump and Bibi at the same time? Sign me up. Netanyahu doesn't need to be tried for corruption. I'll outright say it; the benefits he would've received totaled $250,000 American dollars - why not make yourself a millionaire if you're really corrupt? Doesn't make sense what-so-ever. Next up, Trump!
Source: AP - 🏆 728. / 51 Read more »

Netanyahu's corruption trial to hear first witnesses in JanuaryIsraeli Prime Minister Benjamin Netanyahu's corruption trial will begin in earnest in January with witnesses being heard three times a week, a court decided on Sunday. Convict him, jail him, start a trend. Criminal.
Source: Reuters - 🏆 2. / 97 Read more »